The Pharmaceutical Industries Limited Chief Executive Officer, Ramadhani Madabida
Four persons who are being charged with five counts including supplying counterfeit drugs along with the Pharmaceutical Industries Limited Chief Executive Officer, Ramadhani Madabida were yesterday released on bail after meeting set bail conditions.
However, four accused, Seif Shamte Director of Operations, Simon
Msoffe Marketing Manager and Fatma Shango Assistant Accountant and Evans
Mwemezi, Quality Assurance Officer on Monday failed to meet bail
conditions set by the Kisutu Resident Magistrate court and remain in
custody.
The presiding Senior Resident Magistrate, Nyigulile Mwaseba ordered
the accused to deposit 12m/- in cash each or surrender a title deed of
an immovable property equivalent to the said amount. The magistrate also
ordered each of the accused to secure two reliable sureties to sign a
bond of 6m/-.
As of Monday, only Madabida and Sadiki Materu, Quality Assurance Manager managed to meet the bail conditions.
Apart from supplying counterfeit drugs, Madabida, who is also Dar
es Salaam region’s CCM Chairman, and his co-accused are also charged
with obtaining money by false pretence and occasioning a loss of over
148/- to Medical Stores Department (MSD).
According to the charge sheet, the prosecution team led by Senior
State Attorney, Faraja Nchimbi assisted by State Attorney, Shadrack
Kimaro alleged that on April 5, 2011 in Dar es Salaam, Madabida, Shamte,
Msoffe and Shango supplied to MSD 7,776 Tins of counterfeit
Antiretroviral drugs purportedly containing ingredients Stavudine
30mg+Nevirapine 200mg+Lamivudine 15omg, with batch number OC 01.85
manufactured in March 2011 and expiring on February last year as genuine
Antiretroviral drugs.
In another count it was alleged that between April 12 and 29, 2011
the four accused with intent to defraud or deceive obtained from MSD USD
98,506.8 equivalent to 148,350,156/- by pretending that the amount was
payment for genuine 12,252 Tins of Antiretroviral drugs supplied.
The case was adjourned until February 24, this year.
SOURCE:
THE GUARDIAN
No comments:
Post a Comment